Regeneron (REGN) Tops Q2 EPS by 17c; Updates FY16 Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall Street set to open lower as high-stakes Iran, inflation tests loom
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
Regeneron Reports Second Quarter 2016 Financial and Operating Results
August 4, 2016 6:30 AM EDTTARRYTOWN, N.Y., Aug. 4, 2016 /PRNewswire/ --Â Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)Â today announced financial results for the second quarter of 2016 and provided a business update.
Financial Highlights
($ in millions, except per share data)
Three Months... More
